drugset / Trial / NCT01326403

Tranexamic Acid in Hip Fracture Patients

NCT01326403 ↗

RandomizedSingle-groupTriple-blindPrevention

Summary

This is a randomized controlled trial comparing the use of tranexamic acid to placebo in patients admitted to hospital with a hip fracture.

Timeline

Start
2012-06
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.